J. Banville et al. / Tetrahedron Letters 51 (2010) 3170–3173
3173
11. Schwenker, G.; Stiefvater, K. Arch. Pharm. 1991, 324, 307.
12. Mattay, J.; Mertes, J.; Maas, G. Chem. Ber. 1989, 122, 327.
13. (a) Prokof’ev, E. P.; Karpeiskaya, E. I. Tetrahedron Lett. 1979, 20, 737; (b)
Meanwell, N. A.; Roth, H. R.; Smith, E. C. R.; Wedding, D. L.; Wright, J. J. K. J. Org.
Chem. 1991, 56, 6897.
14. Labadie, J. W.; Tueting, D.; Stille, J. K. J. Org. Chem. 1983, 48, 4634.
15. Labadie, J. W.; Stille, J. K. J. Am. Chem. Soc. 1983, 105, 6129.
16. Liebeskind, L. S.; Wang, J. J. Org. Chem. 1993, 58, 3550.
17. (a) Pais, G. C. G.; Zhang, X.; Marchand, C.; Neamati, N.; Cowansage, K.;
Svarovskaia, E.; Pathak, V. K.; Tang, Y.; Nicklaus, M.; Pommier, Y.; Burke, T. R.,
Jr. J. Med. Chem. 2002, 45, 3184; (b) Andreichikov, Y. S.; Maslivets, A. N.;
Smirnova, L. I.; Krasnykh, O. P.; Kozlov, A. P.; Perevozchikov, L. A. Zh. Org. Chem.
1987, 23, 1534.
18. Williams, H. W. R.; Eichler, E.; Randall, W. C.; Rooney, C. S.; Cragoe, E. J., Jr.;
Streeter, K. B.; Schwam, H.; Michelson, S. R.; Patchett, A. A.; Taub, D. J. Med.
Chem. 1983, 26, 1196.
19. Sof’ina, O. A.; Igidov, N. M.; Koz’minykh, E. N.; Trapeznikova, N. N.; Kasatkina,
Y. S.; Koz’minykh, V. O. Russ. J. Org. Chem. 2001, 37, 1017.
20. (a) Walker, M. A.; Ma, Z.; Naidu, B. N.; Sorenson, M. E.; Pendri, A.; Banville, J.;
Plamondon, S.; Remillard, R. U.S. Patent 7,109,186, 2006; (b) Pace, P.; Spieser, S.
A. H.; Summa, V. Bioorg. Med. Chem. Lett. 2008, 18, 3865.
21. (a) Southwick, P. L.; Seivard, L. L. J. Am. Chem. Soc. 1949, 71, 2532; (b) Merchant,
J. R.; Srivinasan, V. Recl. Trav. Chim. Pays-Bas 1962, 81, 144; (c) Andreichikov, Y.
S.; Gein, V. L. Chem. Heterocycl. Compd. (Engl. Transl.) 1990, 26, 627.
22. Procedures for key compounds:
treated with an alcohol and a trace of base, the dioxolanone ring
was readily cleaved to provide the corresponding ketoester deriv-
ative. For example, reaction of the dioxolanone 19a with MeOH
and a catalytic amount of NaOMe gave the ketoester 24 in high
yield (Table 3, entry 1). The dioxolane ring in 15a could also be
opened by a secondary amine, exemplified by the reaction with
N-benzyl-N-methylamine which gave 25 in 69% yield (Table 3, en-
try 2). Interestingly, while the
a,c-diketoacids and their ester
derivatives exist mainly in the enol form, the amide derivative
25 exists predominantly in the keto form in solution in CHCl3.
2,3-Pyrrolidinediones are highly functionalized heterocycles
which, like the a-ketoacids, have been found to possess HIV integr-
ase inhibitory activity.20 It has been demonstrated that 2,3-pyrro-
lidinediones can be obtained via the Mannich reaction of
a,c-diketoester derivatives with an imine generated in situ from
an aldehyde and a primary amine.21 The dioxolanone scaffold is a
useful substrate for the synthesis of 2,3-pyrrolidinediones. Thus,
reaction of the dioxolanones 15a and 21a with paraformaldehyde
and methylamine in MeOH gave the pyrrolidinenones 26 and 27
in 33% and 40% yield, respectively, after crystallization. Methanol
was found to be essential for the reaction to proceed, which prob-
(S)-(+)-2,2-Dimethyl-5-oxo-1,3-dioxolane-4-acetic acid, tert-butyldimethylsilyl
ester (7b):
A solution of (S)-(+)-2,2-dimethyl-5-oxo-1,3-dioxolane-4-acetic
acid (6) (13.20 g, 75.8 mmol) in DMF (25 mL) was treated at 22 °C with
imidazole (10.56 g, 0.155 mmol) followed by tert-butyldimethylsilyl chloride
(12.0 g, 79.6 mmol) and the resulting mixture was stirred for 18 h. The mixture
was diluted with toluene (500 mL), washed with H2O, saturated NaHCO3, brine,
and dried (MgSO4). The solvent was evaporated under reduced pressure and
the residual oil was distilled under vacuum to give 20.9 g (96% yield) of 7b as a
clear oil, bp 80–90 °C/0.1 torr (bulb–bulb distillation). 1H NMR (C6D6) d 0.33 (s,
3H), 0.36 (s, 3H), 1.0 (s, 9H), 1.11 (s, 3H), 1.37 (s, 3H), 2.72 (AB part of ABX
ably implies the formation of an intermediate
ester prior to pyrrolidinedione formation.
a,c-diketo methyl
In conclusion, we have demonstrated a convenient method for
the synthesis of a selectively protected derivative of oxalacetic acid
that is a useful synthetic precursor to a wide range of products.22 It
can readily be appreciated by the examples described that the
chemistry used to derivatize this starting material is readily ame-
nable to high throughput synthetic methods, an aspect that will
be described in due course. One additional feature of this chemis-
try that is worthy of note is that we have found that the dioxolane
protecting group confers stability to the diketoacid moiety, often
an unstable functional group. For example, when incorporated into
the dioxolane ring, diketoacids such as those described are much
more resistant to decomposition upon storage when compared to
the corresponding free keto-acids.
system, J(AX) = 6.1 Hz, J(BX) = 4.1 Hz, J(AB) = 17.0 Hz,
J(AX) = 6.1 Hz, J(BX) = 4.1 Hz, 1H).
Dm = 41.5 Hz, 2H), 4.35 (dd,
4-Bromo-2,2-dimethyl-5-oxo-1,3–dioxolane-4-acetic acid, tert-butyldimethylsilyl
ester (8b): solution of (S)-(+)-2,2-dimethyl-5-oxo-1,3-dioxolane-4-acetic
A
acid, tert-butyldimethylsilyl ester 7b (20.9 g, 72.4 mmol) in CCl4 (200 mL)
was treated with freshly recrystallized N-bromosuccinimide (14.18 g,
79.6 mmol) and 2,20-azobisisobutyronitrile (0.30 g) and the resulting mixture
was heated under reflux while irradiating with a 500 W lamp. After 5 min, a
mild exothermic reaction was observed and the mixture was heated for an
additional 5 min (at this point most of the succinimide was floating on the
solvent). The mixture was cooled in an ice bath and the succinimide was
filtered and washed with
a small amount of CCl4. The filtrate was used
immediately without further purification for the next step. 1H NMR (CCl4–
CDCl3) d 0.27 and 0.28 (2s, 2 ꢀ 3H), 0.94 (s, 9H), 1.66 (s, 3H), 1.84 (s, 3H), 3.62
(AB system, J(AB) = 21.2 Hz,
Dm = 11.8 Hz, 2H).
Acknowledgment
(Z)-2,2-Dimethyl-5-(tert-butyldimethylsilyloxycarbonylmethylene)-1,3-dioxolan-
4-one (9b): Under vigorous mechanical stirring, the solution of crude ester 8b
(72.4 mmol) in CCl4 (ꢁ220 mL) was cooled to 0–5 °C and treated, dropwise
over 10 min, with a solution of 1,8-diazabicyclo [5,4,0] undec-7-ene (12.1 g,
79.6 mmol) in dry THF (125 mL). A heavy precipitate formed that was difficult
to stir but which gradually became a granular solid. After 1 h, the solid was
filtered and washed with a small amount of THF. The filtrate was concentrated
under reduced pressure to give the crude silyl ester 9b as a light orange oil
which was used as such for the next step. 1H NMR (CDCl3) d 0.33 (s, 6H), 0.97 (s,
9H), 1.75 (s, 6H), 5.85 (s, 1H).
The authors wish to acknowledge Stella Huang for carrying out
the 13C NMR experiments on compound 10.
References and notes
1. Pace, P.; Rowley, M. Curr. Opin. Drug. Discov. Devel. 2008, 11, 471.
2. Hazuda, D. J.; Felock, P.; Witmer, M.; Wolfe, A.; Stillmock, K.; Grobler, J. A.;
Espeseth, A.; Gabryelski, L.; Schleif, W.; Blau, C.; Miller, M. D. Science 2000, 287,
646.
3. Summa, V.; Petrocchi, A.; Pace, P.; Matassa, V. G.; De Francesco, R.; Altamura, V.
G.; Tomei, L.; Koch, U.; Neumer, P. J. Med. Chem. 2004, 47, 14.
(Z)-2,2-Dimethyl-5-carboxymethylene-1,3-dioxolan-4-one (10) from 9b: Crude
dioxolan-4-one 9b (72.4 mmol) in THF (50 mL) was treated at 22 °C with
CH3CO2H (10 mL, 0.17 mmol) followed by H2O (50 mL) and 1 N HCl solution
(20 mL). The mixture was stirred vigorously for 1 h during which time partial
precipitation of the title acid usually occurred. After the addition of EtOAc
(700 mL), the clear solution was washed with H2O, brine, and dried over
anhydrous MgSO4. Evaporation of the solvent under reduced pressure and
trituration of the residual solid with toluene (50 mL) gave 13.58 g of the acid
10 as a white solid (82% yield for three steps from 7b). By 1H NMR this material
contained less than 5% of the (E)-isomer 11. The acid was recrystallized from
EtOAc (80% recovery) to give the pure (Z)-isomer 10 as colorless needles; mp
4. Tumey, L. N.; Huck, B.; Gleason, E.; Wang, J.; Silver, D.; Brunden, K.; Boozer, S.;
Rundlett, S.; Sherf, B.; Murphey, S.; Bailey, A.; Dent, T.; Leventhal, C.;
Harrington, J.; Bennani, Y. L. Bioorg. Med. Chem. Lett. 2004, 14, 4915.
5. Wai, J. S.; Egbertson, M. S.; Payne, L. S.; Fisher, T. E.; Embrey, M. W.; Tran, L. O.;
Melamed, J. Y.; Langford, H. M.; Guare, J. P.; Zhuang, L.; Grey, V. E.; Vacca, J. P.;
Holloway, M. K.; Naylor-Olsen, A. M.; Hazuda, D. J.; Felock, P. J.; Wolfe, A. L.;
Stillmock, K. A.; Schleif, W. A.; Gabrielsky, L. J.; Young, S. D. J. Med. Chem. 2000,
43, 4923.
6. Tapia, I.; Alcazar, V.; Moran, J. R.; Caballero, C.; Grande, M. Chem. Lett. 1990, 5, 697.
7. (a) Walker, M. A.; Johnson, T.; Ma, Z.; Banville, J.; Remillard, R.; Kim, O.; Zhang,
Y.; Staab, A.; Wong, H.; Torri, A.; Samanta, H.; Lin, Z.; Deminie, C.; Terry, B.;
Krystal, M.; Meanwell, N. A. Bioorg. Med. Chem. Lett. 2006, 16, 2920; (b) Walker,
M. A.; Johnson, T.; Ma, Z.; Zhang, Y.; Banville, J.; Remillard, R.; Plamondon, S.;
Pendri, A.; Wong, H.; Smith, D.; Torri, A.; Samanta, H.; Lin, Z.; Deminie, C.;
Terry, B.; Krystal, M.; Meanwell, N. A. Bioorg. Med. Chem. Lett. 2006, 16, 5818.
8. Zhu, K.; Simpson, J. H.; Delaney, E. J.; Nugent, W. A. J. Org. Chem. 2007, 72, 3949.
9. (a) Ramage, R.; Griffiths, G. J.; Shutt, F. E. J. Chem. Soc., Perkin Trans. 1 1984,
1531; (b) Ramage, R.; McCleery, P. P. J. Chem. Soc., Perkin Trans. 1 1984, 1555.
10. Kneer, G.; Mattay, J.; Raabe, G.; Kruger, C.; Lauterwein, J. Synthesis 1990, 599.
203–204 °C (dec.). IR (KBr) m ;
max (1805, 1707 and 1662 cmꢂ1 1H NMR (CDCl3) d
1.78 (s, 6H), 5.89 (s, 1H). Anal. Calcd for C7H8O5: C, 48.84; H, 4.68. Found: C,
48.84; H, 4.65.
(E)-2,2-Dimethyl-5-carboxymethylene-1,3-dioxolan-4-one (11): 1H NMR (CDCl3)
d 1.80 (s, 6H), 6.03 (s, 1H).
(Z)-2,2-Dimethyl-5-chlorocarbonylmethylene-1,3-dioxolan-4-one (12): A mixture
of (Z)-2,2-dimethyl-5-carboxymethylene-1,3-dioxolan-4-one (0.50 g, 2.9 mmol)
in dry CH2Cl2 (10 mL) was treated at 22 °C with oxalyl chloride (0.5 mL,
5.8 mmol) followed by a trace (capillary) of DMF. After 1 h at 22 °C, the clear
solution was concentrated in vacuo to give 0.55 g (quantitative yield) of the title
acid chloride 12 as a white crystalline solid. 1H NMR (CDCl3) d 1.80 (s, 6H), 6.19
(s, 1H).